Skip To Main Content
Jesse Pines on Muck Rack

Jesse Pines

Arlington, United States
As seen in: Forbes, Color Research & Application, TIME, Wiley, Wiley Online Library, Yahoo Canada, Yahoo News Australia, Yahoo News Malaysia, Yahoo News UK, Yahoo Singapore, American Journal of Health-System Pharmacy and
Covers:  healthcare, innovation, artificial intelligence, value-baed care, emergency medicine, integrative medicine
Physician, researcher, policy, economics, innovation, wellness @USACSolutions @Forbes @GWSMHS

Get in touch with Jesse

Contact Jesse, search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack

Actions

Share this page

Jesse Pines’s Biography

Read Full Bio →

Jesse Pines, MD, MBA, MSCE, is Chief of Clinical Innovation at US Acute Care Solutions, the nation's largest physician-owned acute care group. In this role, Dr. Pines leads efforts in artificial intelligence, alternative payment models, telemedicine, research, and other innovations. He also serves as Director of the USACS Fellowship in Clinical Innovation. He is a clinical professor of emergency medicine at George Washington University (GW), and a professor of emergency medicine at Drexel Unive…

Jesse Pines’s Journalist Portfolio

See all →
The UK Passes A Lifetime Smoking Ban. Could America Be Next?

The UK Passes A Lifetime Smoking Ban. Could America Be Next?

The U.K. just banned cigarette sales to anyone born after 2008. A doctor explains what the landmark Tobacco a…

View article →
What Trump's Ibogaine Executive Order Means For Veterans With PTSD

What Trump's Ibogaine Executive Order Means For Veterans With PTSD

Trump signed an executive order to speed ibogaine research for veterans with PTSD. A doctor explains what the…

View article →
RFK Jr. Pushes To Expand Access To Peptides. A Doctor Explains The Risks

RFK Jr. Pushes To Expand Access To Peptides. A Doctor Explains The Risks

A physician examines whether the FDA's loosening of wellness peptide restrictions means these compounds are a…

View article →
New Pancreatic Cancer Drug Nearly Doubles Survival. Here's What Patients Should Know

New Pancreatic Cancer Drug Nearly Doubles Survival. Here's What Patients Should Know

Daraxonrasib, a new pancreatic cancer drug, cut the risk of death by 60% in a Phase 3 trial. A doctor explain…

View article →
Prior Authorization Reform Is Here - And It Could Change How Millions Get Care

Prior Authorization Reform Is Here - And It Could Change How Millions Get Care

Prior authorization forces doctors to spend 13 hours a week fighting insurers. New federal rules are changing…

View article →
Are Nicotine Pouches Like Zyn And VELO Safe To Use? A Doctor Answers

Are Nicotine Pouches Like Zyn And VELO Safe To Use? A Doctor Answers

Zyn nicotine pouches are FDA-authorized but can pose health risks. A doctor breaks down 7 risks from gum dama…

View article →

Articles

ユタ州、処方更新をAIに許可　見えてきた驚きの実態 | Forbes JAPAN 公式サイト（フォーブス ジャパン）

|
By Jesse Pines
| Forbes Japan Verified
1月、ユタ州は自律型AIシステムによる処方更新を認めた初の州となった。これをきっかけに、米国医師会（AMA）、州医療委員会、米食品医薬品局（FDA）、そして増え続ける学術誌を巻き込む議論が起きているが、何が起きたのかについて見解は一致していない。 州の人工知能政策局とAI企業Doctronicの合意に基づき、ユタ州は、米国の他地域では現在義務づけられている医師の関与なしに、同社が一部の処方を更新することを認めた。 用いられた規制上の仕組みは、Doctronicが安全性とプライバシーに関するガードレールを盛り込んだ契約を順守する限り、州が同社に対して非専門職的行為に関する法律を執行しないという合意である。 契約では、DoctronicのAIエージェントは、高血圧、糖尿病、うつ病などの慢性疾患の治療に使われる約190種類の薬について、30日、60日、90日分の更新を1処方あたり4ドル（約1万未満円）で処理できる。これらは、免許を持つ医療提供者がすでに処方した薬であり、新たな治療判断ではない。...
Open in Who Shared Issue with article?

ChatGPT Medical Advice Lawsuit—What The Research Says About AI Diagnosis Original

|
By Jesse Pines
| Forbes Verified
Scott Winters is suing OpenAI, alleging ChatGPT's medical advice delayed treatment for a life-threatening pulmonary embolism. (Photo by Justin Sullivan/Getty Images) Getty Images Scott Winters, a former Florida pastor, is suing OpenAI and its CEO, Sam Altman. The allegation: ChatGPT’s medical advice nearly killed him. According to the lawsuit, filed in San Francisco County Superior Court in July 2026, Winters repeatedly consulted ChatGPT-4o in 2025 about dizziness and unstable blood pressure.
Open in Who Shared View Duplicates (4) Issue with article?

Here Are 3 AI Companies Betting They Can Replace Doctors Original

|
By Jesse Pines
| Forbes Verified
AI tools are increasingly present in the exam room — but a handful of startups want AI to replace doctors. getty Most clinical AI companies today focus on deploying products for functions focused on making doctors faster such as reducing their burnout or helping them make more informed decisions. For example, AI scribes like Abridge and Cleo reduce documentation time and medical-focused AIs like OpenEvidence help doctors make more informed decisions.
Open in Who Shared View Duplicates (2) Issue with article?
See all 259 articles

Interview

See all →

What was your first job as a journalist?

I have never been officially "employed" as a journalist. It has always been a side gig.

How is social media changing news?

Authors can control distribution

How do you prefer to be pitched on stories?

Send me an email